Indefinite Delivery Contract SPE2DR25D9629

The federal contract IDV award SPE2DR25D9629 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 issued by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business. The contract covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers worldwide.

The original solicitation describes the DLA's plan to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract vehicle with multiple regional awards to ensure a diversified supply chain for vital pharmaceuticals. The unrestricted, fully competitive acquisition will have a 30-month base period with three 30-month option periods, for an estimated total value of $30.3 billion. The contract aims to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, the U.S. Coast Guard, and other government agencies, covering medical pharmaceuticals in the 6505 stock catalog/schedule and the current National Drug Code (NDC) database.